To hear about similar clinical trials, please enter your email below
Trial Title:
Low-dose Radiotherapy in iNHL
NCT ID:
NCT05543070
Condition:
Indolent Lymphoma
Low-dose Radiotherapy
Conditions: Official terms:
Lymphoma
Conditions: Keywords:
indolent lymphoma
low-dose radiotherapy
Study type:
Interventional
Study phase:
Phase 2
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Radiation
Intervention name:
Low-dose radiotherapy
Description:
Electron Beam/3D-CRT/IMRT/VMAT
Arm group label:
Low-dose Radiotherapy
Summary:
The current study is a phase II multi-center single arm trial to evaluate the efficacy
and safety of low-dose radiotherapy (3 Gy*4f) in indolent lymphoma.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Pathology proved iNHL
- ECOG PS ≤3
- Signed Informed consent
Exclusion Criteria:
- History of radiotherapy at the same site
- Primary malignant lymphoma of the gastrointestinal tract
- CTV (Clinical Target Volume)>500ml
- Others that researchers consider inappropriate
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Address:
City:
Beijing
Zip:
100021
Country:
China
Status:
Recruiting
Contact:
Last name:
Shunan Qi, MD
Phone:
+861087788995
Email:
medata@163.com
Start date:
May 1, 2022
Completion date:
January 1, 2025
Lead sponsor:
Agency:
Chinese Academy of Medical Sciences
Agency class:
Other
Collaborator:
Agency:
Shanxi Province Cancer Hospital
Agency class:
Other
Collaborator:
Agency:
Beijing Tongren Hospital
Agency class:
Other
Collaborator:
Agency:
Fujian Medical University Union Hospital
Agency class:
Other
Source:
ChineseAMS
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05543070
